Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

UK stocks to outperform as US hits EU with tariffs, says Panmure Liberum

(Sharecast News) - Broker Panmure Liberum believes the newly announced tariffs on EU imports into the US will turn the UK into a "trade war winner", resulting in an outperformance by London-listed stocks compared with their continental peers. "As the world stands today, there is one clear recommendation: Buy UK," the broker said.

Financial markets across the globe on Monday were digested Donald Trump's latest trade war rhetoric, after the US President said on Saturday that he was planning to impose 30% levies on imports from the European Union and Mexico from 1 August.

The figure was far more than what many analysts - and EU nations - had expected, following the 10% tariff secured by the UK in a trade deal announced last month.

"By now, investors know the drill: A lot will change between today and 1 August, and the numbers thrown around at the moment are so high that they are ridiculous," Panmure Liberum said in a research note. "However, while Trump cannot be taken literally, we think he still needs to be taken seriously. We think that the EU will face many obstacles to getting a trade deal over the line by the end of this month."

As for UK businesses, Panmure Liberum believes that, given trade uncertainty is much lower than for their European counterparts, stocks should be "much more resilient in the coming weeks".

What's more, the broker also sees a large arbitrage opportunities for European companies diverting exports to the US via the UK, which will result in higher foreign direct investments in manufacturing sites and warehouses in the UK over the next three to five years.

"Because the UK is subject to 10% tariffs and tariffs for exports from the EU to the UK are typically 10%, EU manufacturers could ship goods from the EU to the UK, slightly alter them in the UK to turn them into 'Made in the UK' goods, and then ship them to the US," the broker said.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.